Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.78 USD | +2.24% | -1.16% | -26.35% |
04-09 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
04-03 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bearish | Bearish |
Resistance | 18.42 | 19.44 | 20.93 |
Spread/Res. | -14.20% | -18.70% | -24.49% |
Spread/Supp. | +5.65% | +5.65% | +9.76% |
Support | 14.96 | 14.96 | 14.40 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- DNLI Stock
- Charts Denali Therapeutics Inc.